Manulife (Manufacturers Life Insurance)
ACET icon

Manulife (Manufacturers Life Insurance)’s Adicet Bio ACET Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,006
Closed -$37.8K – 2960
2024
Q1 		$37.8K Buy
+1,006
New +$41.6K ﹤0.01% 2906
2023
Q2 		– Sell
-716
Closed -$66K – 2962
2023
Q1 		$66K Hold
716
– – ﹤0.01% 2821
2022
Q4 		$102K Sell
716
-7
-1% -$1.75K ﹤0.01% 2792
2022
Q3 		$165K Sell
723
-20
-3% -$5.08K ﹤0.01% 2672
2022
Q2 		$174K Buy
743
+79
+12% +$17.3K ﹤0.01% 2725
2022
Q1 		$212K Sell
664
-14
-2% -$3.22K ﹤0.01% 2735
2021
Q4 		$190 Buy
+678
New +$116K ﹤0.01% 2910
2019
Q4 		– Sell
-98
Closed -$96K – 2863
2019
Q3 		$96K Hold
98
– – ﹤0.01% 2829
2019
Q2 		$112K Buy
+98
New +$88.8K ﹤0.01% 2868
2018
Q3 		– Sell
-1
Closed -$1K – 2929
2018
Q2 		$1K Buy
+1
New +$1.08K ﹤0.01% 4234

Other funds holding ACET

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s ACET Position: Q2 2024 in Review

Manulife (Manufacturers Life Insurance) sold out of Adicet Bio (ACET) in Q2 2024, closing a stake of 1,006 shares — an estimated $37.8K sold.

Manulife (Manufacturers Life Insurance) first reported a position in ACET in Q2 2018 and held it in 10 quarters. The position peaked at $212K in Q1 2022. 86 funds tracked by Wall St. Rank hold ACET as of Q2 2024.

  • Manulife (Manufacturers Life Insurance) reported no remaining Adicet Bio position as of Q2 2024 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 1,006 Adicet Bio shares in Q2 2024, an estimated $37.8K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Adicet Bio in Q2 2018 and held it in 10 quarters.
  • Manulife (Manufacturers Life Insurance)'s Adicet Bio position peaked at $212K in Q1 2022.
  • 86 funds tracked by Wall St. Rank held Adicet Bio as of Q2 2024.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2024, filed 14 Aug 2024.